Nurse Practitioner, Family · Fresno, CA
NPI
1922167857
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1053 R St
Fresno, CA, 93721
Phone (559) 233-3131
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$938K
6,621 prescriptions
Company payments, 2025
$2,718
From 12 companies
Medicare prescription drug claims, 2024
In 2024, the drug Nellie V Go prescribed most often to Medicare patients was Famotidine, with 336 prescriptions and refills. In total Nellie V Go wrote 6,621 Medicare prescriptions that cost $938K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Famotidine Generic | 336 | 337 | 50 | $2,550 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 306 | 306 | 52 | $11K |
| Atorvastatin Calcium Generic | 304 | 306 | 42 | $2,723 |
| Amlodipine Besylate Generic | 295 | 301 | 35 | $1,328 |
| Buspirone Hcl Generic | 224 | 224 | 37 | $983 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 209 | 209 | 44 | $140K |
| Rosuvastatin Calcium Generic | 178 | 178 | 25 | $1,377 |
| Gabapentin Generic | 177 | 178 | 33 | $1,232 |
| Propylthiouracil Generic | 136 | 136 | 17 | $2,901 |
| Tramadol Hcl Generic | 129 | 129 | 17 | $516 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 125 | 125 | 20 | $1,852 |
| Baclofen Generic | 119 | 119 | 23 | $832 |
| Levothyroxine Sodium Generic | 116 | 116 | 13 | $2,423 |
| Benazepril Hcl Generic | 109 | 109 | 16 | $902 |
| Tamsulosin Hcl Generic | 108 | 117 | 18 | $736 |
Brand drugs: 1,497 claims; generic drugs: 5,062 claims; opioid claims: 257.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nellie V Go $2,718 ($2,718 in general payments such as food, travel and fees) from 12 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $848.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 31 | $848 |
| GlaxoSmithKline, LLC. GSK | 13 | $369 |
| Amgen Inc. AMGN | 22 | $326 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $306 |
| Vanda Pharmaceuticals Inc. VNDA | 7 | $267 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $170 |
| Mannkind Corporation MNKD | 8 | $155 |
| Pfizer Inc. PFE | 4 | $89.11 |
| Ardelyx, Inc. ARDX | 3 | $74.03 |
| Lundbeck LLC | 3 | $59.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.